These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 9803668)
21. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791 [TBL] [Abstract][Full Text] [Related]
22. Diacylglycerol acyltransferase-inhibitory compounds from Erythrina senegalensis. Oh WK; Lee C; Seo JH; Chung MY; Cui L; Fomum ZT; Kang JS; Lee HS Arch Pharm Res; 2009 Jan; 32(1):43-7. PubMed ID: 19183875 [TBL] [Abstract][Full Text] [Related]
23. Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitors. Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L J Med Chem; 2008 Mar; 51(5):1474-7. PubMed ID: 18284184 [TBL] [Abstract][Full Text] [Related]
24. A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis: evidence for catalytic difference between ACAT1 and ACAT2. An S; Cho KH; Lee WS; Lee JO; Paik YK; Jeong TS FEBS Lett; 2006 May; 580(11):2741-9. PubMed ID: 16647063 [TBL] [Abstract][Full Text] [Related]
25. Bavachin and isobavachalcone, acyl-coenzyme A: cholesterol acyltransferase inhibitors from Psoralea corylifolia. Choi JH; Rho MC; Lee SW; Choi JN; Kim K; Song GY; Kim YK Arch Pharm Res; 2008 Nov; 31(11):1419-23. PubMed ID: 19023538 [TBL] [Abstract][Full Text] [Related]
26. Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists. Singh P; Kumar R J Enzyme Inhib; 2001 Oct; 16(4):331-8. PubMed ID: 11916138 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2. Ohtawa M; Yamazaki H; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T Bioorg Med Chem Lett; 2013 May; 23(9):2659-62. PubMed ID: 23535327 [TBL] [Abstract][Full Text] [Related]
28. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase. Venkatarangan P; Hopfinger AJ J Med Chem; 1999 Jun; 42(12):2169-79. PubMed ID: 10377222 [TBL] [Abstract][Full Text] [Related]
29. Differences in the potency of ACAT inhibitors in two assay systems. Harte RA; Jackson B; Suckling KE; Yeaman SJ Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):325S. PubMed ID: 8224469 [No Abstract] [Full Text] [Related]
30. Effect of 3,4-di(OH)-cinnamate synthetic derivative on plasma and hepatic cholesterol level and antioxidant enzyme activities in high cholesterol-fed rats. Park EJ; Lee S; Jeong TS; Bok SH; Lee MK; Park YB; Choi MS J Biochem Mol Toxicol; 2004; 18(5):279-87. PubMed ID: 15549704 [TBL] [Abstract][Full Text] [Related]
31. Antinociceptive and antiinflammatory activities and QSAR studies on 2-substituted-4,5-diphenyl-1H-imidazoles. Puratchikody A; Doble M Bioorg Med Chem; 2007 Jan; 15(2):1083-90. PubMed ID: 17079151 [TBL] [Abstract][Full Text] [Related]
32. Effect of molecular size on the activity of adriamycin analogues: a quantitative structure-activity relationship study. Prabhakar YS; Gupta SP; Ray A J Pharmacobiodyn; 1986 Jan; 9(1):61-7. PubMed ID: 3458905 [TBL] [Abstract][Full Text] [Related]
33. QSAR Studies on antiepileptic and locomotor in vivo activities of 4,5-diphenyl-1H-imidazoles. Puratchikody A; Doble M Chem Biol Drug Des; 2009 Aug; 74(2):173-82. PubMed ID: 19549087 [TBL] [Abstract][Full Text] [Related]
34. ACAT inhibition of alkamides identified in the fruits of Piper nigrum. Rho MC; Lee SW; Park HR; Choi JH; Kang JY; Kim K; Lee HS; Kim YK Phytochemistry; 2007 Mar; 68(6):899-903. PubMed ID: 17188313 [TBL] [Abstract][Full Text] [Related]
35. Exploring QSAR on 3-aminopyrazoles as antitumor agents for their inhibitory activity of CDK2/cyclin A. Samanta S; Debnath B; Basu A; Gayen S; Srikanth K; Jha T Eur J Med Chem; 2006 Oct; 41(10):1190-5. PubMed ID: 16806589 [TBL] [Abstract][Full Text] [Related]
37. A strategy for quantitative bioanalysis of non-polar neutral compounds by liquid chromatography/electrospray ionization tandem mass spectrometry: determination of TS-962, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in rabbit aorta and liver tissues. Yamaguchi J; Matsuno Y; Hachiuma K; Ogawa N; Higuchi S Rapid Commun Mass Spectrom; 2001; 15(8):629-36. PubMed ID: 11312514 [TBL] [Abstract][Full Text] [Related]
38. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis. Debnath AK J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730 [TBL] [Abstract][Full Text] [Related]
39. Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists. Lippa B; Morris J; Corbett M; Kwan TA; Noe MC; Snow SL; Gant TG; Mangiaracina M; Coffey HA; Foster B; Knauth EA; Wessel MD Bioorg Med Chem Lett; 2006 Jul; 16(13):3444-8. PubMed ID: 16632359 [TBL] [Abstract][Full Text] [Related]
40. A QSAR study on renin inhibitors. Gupta SP; Gupta JK; Nagappa AN; Jagannathan V; Gangwal D Drug Des Deliv; 1989 Dec; 5(2):73-80. PubMed ID: 2577988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]